Sos-mediated cross-activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis

Nature Communications

Volumn 3, Issue , 2012, Pages

  Jeng, Hao Hsuan ^a   Taylor, Laura J ^a   Bar Sagi, Dafna ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; SOS PROTEIN;

CANCER; CELL ORGANELLE; GENE; MUTATION; PHENOTYPE; TUMOR;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL GROWTH; CELL TRANSFORMATION; CONTROLLED STUDY; GENE ACTIVATION; HUMAN; HUMAN CELL; ONCOGENE H RAS; ONCOGENE N RAS;

ALLOSTERIC REGULATION; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENES, RAS; HUMANS; MICE; MICE, NUDE; PROTEIN ISOFORMS; RAS PROTEINS; SIGNAL TRANSDUCTION; SON OF SEVENLESS PROTEIN, DROSOPHILA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MAMMALIA;

EID: 84869447282     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2173     Document Type: Article

References (30)

1. Bos, J.L., Rehmann, H. & Wittinghofer, A. GEFs and GAPs: critical elements in the control of small G proteins. Cell 129, 865-877 (2007). (Pubitemid 46802708)
2. Chardin, P. et al. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science 260, 1338-1343 (1993). (Pubitemid 23231980)
3. Margarit, S.M. et al. Structural evidence for feedback activation by Ras.GTP of the Ras-specific nucleotide exchange factor SOS. Cell 112, 685-695 (2003). (Pubitemid 36331780)
4. Sondermann, H. et al. Structural analysis of autoinhibition in the Ras activator Son ofsevenless. Cell 119, 393-405 (2004). (Pubitemid 39423841)
5. Gureasko, J. et al. Membrane-dependent signal integration by the Ras activator Son of sevenless. Nat Struct. Mol. Biol. 15, 452-461 (2008). (Pubitemid 351653589)
6. Buick, R.N., Filmus, J. & Quaroni, A. Activated H-ras transforms rat intestinal epithelial cells with expression of alpha-TGF. Exp. Cell. Res. 170, 300-309 (1987). (Pubitemid 17093682)
7. Ciardiello, F. et al. Expression oftransforming growth factor alpha (TGF alpha) in breast cancer. Ann. Oncol. 2, 169-182 (1991).
8. Dlugosz, A.A. et al. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands. Cancer Res. 55, 1883-1893 (1995).
9. Grana, T.M., Sartor, C.I. & Cox, A.D. Epidermal growth factor receptor autocrine signaling in RIE-1 cells transformed by the Ras oncogene enhances radiation resistance. Cancer Res. 63, 7807-7814 (2003). (Pubitemid 37466713)
10. Bowtell, D., Fu, P., Simon, M. & Senior, P. Identification ofmurine homologues of the Drosophila son ofsevenless gene: potential activators ofras. Proc. Natl Acad. Sci. USA 89, 6511-6515 (1992).
11. Nielsen, K.H., Papageorge, A.G., Vass, W.C., Willumsen, B.M. & Lowy, D.R. The Ras-specific exchange factors mouse Sos1 (mSos1) and mSos2 are regulated differently: mSos2 contains ubiquitination signals absent in mSos1. Mol. CellBiol. 17, 7132-7138 (1997). (Pubitemid 27505943)
12. Kamioka, Y., Yasuda, S., Fujita, Y., Aoki, K. & Matsuda, M. Multiple decisive phosphorylation sites for the negative feedback regulation of SOS1 via ERK. J. Biol. Chem. 285, 33540-33548 (2010).
13. Buday, L. & Downward, J. Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell 73, 611-620 (1993). (Pubitemid 23143358)
14. Gale, N.W., Kaplan, S., Lowenstein, E.J., Schlessinger, J. & Bar-Sagi, D. Grb2 mediates the EGF-dependent activation ofguanine nucleotide exchange on Ras. Nature 363, 88-92 (1993). (Pubitemid 23144969)
15. Li, N. et al. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 363, 85-88 (1993). (Pubitemid 23144968)
16. Egan, S.E. et al. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363, 45-51 (1993). (Pubitemid 23144959)
17. Hamilton, M. & Wolfman, A. Ha-ras and N-ras regulate MAPK activity by distinct mechanisms in vivo. Oncogene 16, 1417-1428 (1998). (Pubitemid 28151849)
18. Lim, K.H., Ancrile, B.B., Kashatus, D.F. & Counter, C.M. Tumour maintenance is mediated by eNOS. Nature 452, 646-649 (2008). (Pubitemid 351483359)
19. Bos, J.L. Ras oncogenes in human cancer: a review. CancerRes. 49, 4682-4689 (1989). (Pubitemid 19213607)
20. Hall, B.E., Yang, S.S., Boriack-Sjodin, P.A., Kuriyan, J. & Bar-Sagi, D. Structure-based mutagenesis reveals distinct functions for Ras switch 1 and switch 2 in Sos-catalyzed guanine nucleotide exchange. J. Biol. Chem. 276, 27629-27637 (2001).
21. McCubrey, J.A. et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim. Biophys. Acta. 1773, 1263-1284 (2007). (Pubitemid 47125967)
22. Engelman, J.A. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev. Cancer 9, 550-562 (2009).
23. Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P. & Pandolfi, P.P. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121, 179-193 (2005). (Pubitemid 40546387)
24. Yan, J., Roy, S., Apolloni, A., Lane, A. & Hancock, J.F. Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J. Biol. Chem. 273, 24052-24056 (1998). (Pubitemid 28435747)
25. Voice, J.K., Klemke, R.L., Le, A. & Jackson, J.H. Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J. Biol. Chem. 274, 17164-17170 (1999).
26. Fotiadou, P.P., Takahashi, C., Rajabi, H.N. & Ewen, M.E. Wild-type NRas and KRas perform distinct functions during transformation. Mol. Cell. Biol. 27, 6742-6755 (2007). (Pubitemid 47483626)
27. To, M.D. et al. Kras regulatory elements and exon 4A determine mutation specificity in lung cancer. Nat Genet. 40, 1240-1244 (2008).
28. Matallanas, D. et al. Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras. Mol. Cell 44, 893-906 (2011).
29. Diaz, R. et al. The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene. CancerRes. 62, 4514-4518 (2002). (Pubitemid 34827316)
30. Boykevisch, S. et al. Regulation of ras signalling dynamics by Sos-mediated positive feedback. Curr. Biol. 16, 2173-2179 (2006). (Pubitemid 44767628)